Boston Scientific (NYSE:BSX) Price Target Increased to $90.00 by Analysts at Citigroup
Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Citigroup from $87.00 to $90.00 in a research report released on Wednesday morning, Benzinga reports. The firm currently has a buy rating on the medical equipment provider’s stock. A number of other research firms have also issued reports on BSX. Evercore ISI increased […]
More Stories
Short Interest in Wyndham Hotels & Resorts, Inc. (NYSE:WH) Declines By 31.4%
Wyndham Hotels & Resorts, Inc. (NYSE:WH – Get Free Report) was the recipient of a significant decrease in short interest...
Dawson Geophysical (NASDAQ:DWSN) Sees Significant Decrease in Short Interest
Dawson Geophysical (NASDAQ:DWSN – Get Free Report) was the target of a significant drop in short interest during the month...
Acasti Pharma (CVE:ACST) Trading 1.8% Higher – Time to Buy?
Shares of Acasti Pharma Inc. (CVE:ACST – Get Free Report) traded up 1.8% during mid-day trading on Wednesday . The...
Laser Photonics (NASDAQ:LASE) Shares Down 7% – Should You Sell?
Laser Photonics Co. (NASDAQ:LASE – Get Free Report)’s share price dropped 7% on Wednesday . The company traded as low...
Poupak Bahamin Sells 2,500 Shares of Barrick Gold Co. (TSE:ABX) Stock
Barrick Gold Co. (TSE:ABX – Get Free Report) (NYSE:ABX) Senior Officer Poupak Bahamin sold 2,500 shares of the business’s stock...
Short Interest in Eaton Vance Short Duration Income ETF (NASDAQ:EVSD) Expands By 466.7%
Eaton Vance Short Duration Income ETF (NASDAQ:EVSD – Get Free Report) was the recipient of a significant growth in short...